Jatinder Pruthi

Statistics

Publications

Citations

436

H-Index

Active since

2001

Affiliations

Janssen (United States)(Current)

Hospital Clínic de Barcelona

Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas

Kyorin University

Western University

Jatinder Pruthi is an author at Janssen (United States) specializing in crohn disease pharmacotherapy, gastrointestinal pharmacotherapy, and clinical sciences.

Publications per year

2001–2024

Publications

Analysis of causes of death in liver transplant recipients who survived more than 3 years

Jatinder Pruthi · Liver Transplantation · 2001 · 283 citations

Medicine, Surgery, Hepatology +11

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 83 citations · Full text

Pharmacy, Clinical Sciences, Pharmacotherapy +15

Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial

Silvio Danese, Remo Panaccione, Brian G. Feagan et al. · The Lancet. Gastroenterology & hepatology · 2023 · 70 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +6

1–3 of 3